instead designed a register-based cohort study, including more than 10,000 children with maternal exposure to metformin or insulin regardless of the indication (GDM, presentational T2DM, or PCOS), classified into three exposure groups: metformin, insulin, and combination treatment (15). This evidence concerns the gene INS and polycystic ovary syndrome.